Jürgen Hubbuch
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Jürgen Hubbuch has a total of 355 co-authors. Here are the top co-authors by number of shared publications:
- Stefan Alexander Oelmeier
Karlsruhe Institute of Technology, Institute of Process Engineering in Life Sciences, Section IV: Biomolecular Separation Engineering, Karlsruhe, Germany; Boehringer Ingelheim Pharma GmbH & Co. KG, Germany
13 shared publications Tobias Hahn
GoSilico GmbH, Kriegsstr. 240, Karlsruhe 76135, Germany
13 shared publicationsTill Briskot
Global Development CMC Biologicals, Boehringer Ingelheim Pharma GmbH & Co. KG, Biberach, Germany
12 shared publicationsGang Wang
DSP Development, Boehringer Ingelheim Pharma GmbH & Co. KG, Biberach, Germany
11 shared publications- Matthias Rüdt
Institute of Engineering in Life Sciences, Section IV: Biomolecular Separation Engineering, Karlsruhe Institute of Technology (KIT), Karlsruhe, Germany
9 shared publications - David Saleh
DSP Development, Boehringer Ingelheim Pharma GmbH & Co. KG, Biberach, Germany
7 shared publications
Latest Publications
- Open Access
DNA Methylation Profiling of rAAVs Reveals Hypomethylated Genomes and Evidence for Predominant Packaging of Replicated Genomes
Immune responses to recombinant adeno-associated viral vectors (rAAVs) impair the therapeutic potential of gene therapies. One trigger for these responses upon systemic administration is the activation of Toll-like receptor 9 by unmethylated cytosine–phosphate–guanine motifs within the vector genome. To better understand the epigenetic profile of rAAVs, we performed bisulfite sequencing on vector genomes produced either via standard triple transfection or via a stable cell line. Furthermore, we investigated whether the epigenetic state of the template DNA influences the encapsidated genome by using in vitro-methylated plasmids during triple transfection. Our results demonstrate that, regardless of the production platform, rAAV genomes lack substantial CpG methylation. Notably, even when a fully CpG-methylated template plasmid was used, the resulting vector DNA exhibited only 4.56% methylation, indicating that alternative strategies—beyond modifying the template DNA—are required to reduce CpG-associated immunogenicity. Additionally, comparing the methylation patterns of rAAVs generated from GpC- and CpG-methylated plasmids revealed that vector genomes were predominantly packaged following genome replication rather than directly from the plasmid DNA. These findings provide critical insights into rAAV packaging mechanisms and inform future strategies for vector engineering.
Open AccessDNA Methylation Profiling of rAAVs Reveals Hypomethylated Genomes and Evidence for Predominant Packaging of Replicated Genomes
Immune responses to recombinant adeno-associated viral vectors (rAAVs) impair the therapeutic potential of gene therapies. One trigger for these responses upon systemic administration is the activation of Toll-like receptor 9 by unmethylated cytosine–phosphate–guanine motifs within the vector genome. To better understand the epigenetic profile of rAAVs, we performed bisulfite sequencing on vector genomes produced either via standard triple transfection or via a stable cell line. Furthermore, we investigated whether the epigenetic state of the template DNA influences the encapsidated genome by using in vitro-methylated plasmids during triple transfection. Our results demonstrate that, regardless of the production platform, rAAV genomes lack substantial CpG methylation. Notably, even when a fully CpG-methylated template plasmid was used, the resulting vector DNA exhibited only 4.56% methylation, indicating that alternative strategies—beyond modifying the template DNA—are required to reduce CpG-associated immunogenicity. Additionally, comparing the methylation patterns of rAAVs generated from GpC- and CpG-methylated plasmids revealed that vector genomes were predominantly packaged following genome replication rather than directly from the plasmid DNA. These findings provide critical insights into rAAV packaging mechanisms and inform future strategies for vector engineering.
- Open Access
- 13 October 2026
- Published by Frontiers Media SA in Frontiers in Bioengineering and Biotechnology
- Vol. 14, 1913731
UV-derived scattering as a high-throughput readout for adeno-associated virus-like particle separation screenings
Virus-like particles (VLPs), including those derived from adeno-associated virus (AAV), are increasingly investigated for vaccination, capsid engineering, and gene-delivery applications. Although precipitation and aqueous two-phase separation (ATPS) represent promising alternatives to adsorption-based capture, their optimization is limited by the lack of rapid analytical methods suitable for complex process samples. Here, VP3-only AAV5 VLPs produced in Escherichia coli were used as a model system to evaluate UV-derived light scattering as a high-throughput separation readout. Blank-corrected absorbance at 320 nm was used as a relative descriptor of particulate-associated scattering, while scattering-corrected absorbance at 280 nm monitored the soluble biomolecular fraction. During PEG precipitation, A320 showed condition-dependent agreement with anti-AAV5 ELISA, with the closest correspondence for PEG4000 and increasing divergence at lower PEG molecular weights. Capsid-spiking experiments further showed that dispersed intact capsids alone contributed only marginally to A320, indicating that the signal primarily reflects larger scattering-active structures accompanying capsid depletion. The workflow enabled screening and analysis of 170 precipitation and PEG/phosphate ATPS conditions in biological duplicate within 3 days. Low-molecular-weight PEG systems provided stronger separation between soluble biomolecular material and particulate-associated scattering. In PEG400 ATPS, pH altered the distribution of scattering-active material and capsids between the liquid phases and interphase, whereas selected precipitation conditions showed higher recovery of assembled capsids after resolubilization than ATPS, at the expense of lower impurity removal. Overall, UV-derived scattering provides a rapid, scalable first-line readout for comparing separation conditions and reducing the number of samples requiring capsid-specific and structural characterization.
- 13 October 2026
- Published by Frontiers Media SA in Frontiers in Bioengineering and Biotechnology
- Vol. 14, 1913731
Open AccessUV-derived scattering as a high-throughput readout for adeno-associated virus-like particle separation screenings
Virus-like particles (VLPs), including those derived from adeno-associated virus (AAV), are increasingly investigated for vaccination, capsid engineering, and gene-delivery applications. Although precipitation and aqueous two-phase separation (ATPS) represent promising alternatives to adsorption-based capture, their optimization is limited by the lack of rapid analytical methods suitable for complex process samples. Here, VP3-only AAV5 VLPs produced in Escherichia coli were used as a model system to evaluate UV-derived light scattering as a high-throughput separation readout. Blank-corrected absorbance at 320 nm was used as a relative descriptor of particulate-associated scattering, while scattering-corrected absorbance at 280 nm monitored the soluble biomolecular fraction. During PEG precipitation, A320 showed condition-dependent agreement with anti-AAV5 ELISA, with the closest correspondence for PEG4000 and increasing divergence at lower PEG molecular weights. Capsid-spiking experiments further showed that dispersed intact capsids alone contributed only marginally to A320, indicating that the signal primarily reflects larger scattering-active structures accompanying capsid depletion. The workflow enabled screening and analysis of 170 precipitation and PEG/phosphate ATPS conditions in biological duplicate within 3 days. Low-molecular-weight PEG systems provided stronger separation between soluble biomolecular material and particulate-associated scattering. In PEG400 ATPS, pH altered the distribution of scattering-active material and capsids between the liquid phases and interphase, whereas selected precipitation conditions showed higher recovery of assembled capsids after resolubilization than ATPS, at the expense of lower impurity removal. Overall, UV-derived scattering provides a rapid, scalable first-line readout for comparing separation conditions and reducing the number of samples requiring capsid-specific and structural characterization.
- Open Access
- 2 September 2026
- Published by Wiley in Biotechnology Progress
- p. e88547
DNA concentration in harvest affects retrovirus clearance capabilities of protein A chromatography
Protein A chromatography is a key unit operation in biopharmaceutical purification, widely used to capture monoclonal antibodies (mAbs) from harvest cell culture fluid (HCCF). In addition to its primary function, protein A chromatography is also frequently tested for its ability to remove viruses. Although protein A specifically binds mAbs and should not interact with viruses, some studies have shown that logarithmic reduction values (LRVs) can vary between 1 and 4 log 10 for retroviruses. This variance has been shown to depend on the mAb and feedstock compositions. However, it has not been evaluated so far which feedstock ingredients affect virus removal. To address this knowledge gap, a data set of virus spiking studies was analyzed and revealed a potential correlation between DNA content in HCCF and LRV of protein A chromatography. To evaluate this hypothesis, experiments with murine leukemia virus (MuLV) and retrovirus like particles (RVLP) spiked starting materials of three different mAbs were performed. In general, higher HCCF DNA levels were found to enhance LRV for both virus particles. A trend that was confirmed with RVLP spiked pure mAb. In addition, protein A chromatography washing buffers containing a detergent or a reducing agent were shown to improve LRV in RVLP spiked experiments. This study demonstrates the effect of DNA concentration on the virus removal capabilities of protein A chromatography. Findings that are especially useful when DNA is removed at early stages of the downstream process, for example by using functionalized depth filters or precipitation.
- 2 September 2026
- Published by Wiley in Biotechnology Progress
- p. e88547
Open AccessDNA concentration in harvest affects retrovirus clearance capabilities of protein A chromatography
Protein A chromatography is a key unit operation in biopharmaceutical purification, widely used to capture monoclonal antibodies (mAbs) from harvest cell culture fluid (HCCF). In addition to its primary function, protein A chromatography is also frequently tested for its ability to remove viruses. Although protein A specifically binds mAbs and should not interact with viruses, some studies have shown that logarithmic reduction values (LRVs) can vary between 1 and 4 log 10 for retroviruses. This variance has been shown to depend on the mAb and feedstock compositions. However, it has not been evaluated so far which feedstock ingredients affect virus removal. To address this knowledge gap, a data set of virus spiking studies was analyzed and revealed a potential correlation between DNA content in HCCF and LRV of protein A chromatography. To evaluate this hypothesis, experiments with murine leukemia virus (MuLV) and retrovirus like particles (RVLP) spiked starting materials of three different mAbs were performed. In general, higher HCCF DNA levels were found to enhance LRV for both virus particles. A trend that was confirmed with RVLP spiked pure mAb. In addition, protein A chromatography washing buffers containing a detergent or a reducing agent were shown to improve LRV in RVLP spiked experiments. This study demonstrates the effect of DNA concentration on the virus removal capabilities of protein A chromatography. Findings that are especially useful when DNA is removed at early stages of the downstream process, for example by using functionalized depth filters or precipitation.
- Open Access
- 4 August 2026
- Published by Elsevier in Journal of Chromatography A
- Vol. 1785, 467325
A modeling framework for uncertainty quantification in filter-plate-based high-throughput screening of the chromatography partition coefficient
- 4 August 2026
- Published by Elsevier in Journal of Chromatography A
- Vol. 1785, 467325
Open AccessA modeling framework for uncertainty quantification in filter-plate-based high-throughput screening of the chromatography partition coefficient
- Open Access
- 25 June 2026
- Published by Wiley in Biotechnology Progress
- Vol. 42 (5) , e88534
Mechanistic deconvolution of BSA size variants by constrained Raman pseudo‐Voigt hard modeling during anion‐exchange chromatography
In biopharmaceutical manufacturing, protein aggregation is a critical quality attribute, necessitating rapid and reliable analytical strategies during downstream processes like anion‐exchange chromatography (AEX). While Raman spectroscopy enables continuous monitoring of protein secondary structure, standard data‐driven regression models struggle to decouple intrinsic structural changes from gradient‐induced solvent and buffer drifts under dynamic chromatographic conditions. Addressing this methodological gap, this study establishes a constrained pseudo‐Voigt hard modeling framework for the mechanistic deconvolution of bovine serum albumin (BSA) size variants during in‐line Raman monitoring of AEX processes. By explicitly defining a parametric background model to capture salt‐induced spectral drift, the methodology effectively isolates matrix variations from genuine protein‐specific signals. The constrained hard model was applied to 285 in‐line spectra across diverse chromatographic conditions, achieving reconstruction fidelity while maintaining stable, physically interpretable component identities. The mechanistically derived Amide I center of mass emerged as a robust, aggregation‐sensitive descriptor that preserves structural information despite strong concentration dynamics. Furthermore, the extracted spectral features demonstrated strong predictive performance for monomer concentration and acceptable accuracy for high molecular weight components. Collectively, these results demonstrate that constrained spectral hard modeling provides a highly interpretable, robust, and calibration‐light alternative to classical partial least squares approaches for the real‐time monitoring of protein size variants.
- 25 June 2026
- Published by Wiley in Biotechnology Progress
- Vol. 42 (5) , e88534
Open AccessMechanistic deconvolution of BSA size variants by constrained Raman pseudo‐Voigt hard modeling during anion‐exchange chromatography
In biopharmaceutical manufacturing, protein aggregation is a critical quality attribute, necessitating rapid and reliable analytical strategies during downstream processes like anion‐exchange chromatography (AEX). While Raman spectroscopy enables continuous monitoring of protein secondary structure, standard data‐driven regression models struggle to decouple intrinsic structural changes from gradient‐induced solvent and buffer drifts under dynamic chromatographic conditions. Addressing this methodological gap, this study establishes a constrained pseudo‐Voigt hard modeling framework for the mechanistic deconvolution of bovine serum albumin (BSA) size variants during in‐line Raman monitoring of AEX processes. By explicitly defining a parametric background model to capture salt‐induced spectral drift, the methodology effectively isolates matrix variations from genuine protein‐specific signals. The constrained hard model was applied to 285 in‐line spectra across diverse chromatographic conditions, achieving reconstruction fidelity while maintaining stable, physically interpretable component identities. The mechanistically derived Amide I center of mass emerged as a robust, aggregation‐sensitive descriptor that preserves structural information despite strong concentration dynamics. Furthermore, the extracted spectral features demonstrated strong predictive performance for monomer concentration and acceptable accuracy for high molecular weight components. Collectively, these results demonstrate that constrained spectral hard modeling provides a highly interpretable, robust, and calibration‐light alternative to classical partial least squares approaches for the real‐time monitoring of protein size variants.
- Open Access
- 2 April 2026
- Published by Springer Nature in Scientific Reports
- Vol. 16 (1)
Proof of concept for aqueous two-phase system-based extraction of cell-free DNA from plasma for liquid biopsy applications
Efficient extraction of circulating cell-free DNA (cfDNA) from plasma is critical for liquid biopsy applications, but remains challenging due to cfDNA’s short fragment size, low concentration, and the presence of interfering proteins and genomic DNA. This study presents a simple extraction process based on aqueous two-phase system (ATPS) capture and reverse elution purification as a potentially lysis-free alternative to adsorption-based methods. Short DNA fragments selectively partitioned into the salt-rich bottom phase, achieving up to 65% recovery after purification while removing 99.7% of plasma proteins. Reverse elution enabled efficient desalting and up to fourfold DNA concentration under mild, aqueous conditions. The extracts showed no qPCR inhibition and displayed a cfDNA-like size profile with a cutoff around 750 bp, indicating selective enrichment of short fragments. Although the total yield was slightly lower than that of the QIAamp Circulating Nucleic Acid Kit (QIAGEN), the ATPS workflow substantially reduced processing time, equipment needs, and cost. Next-generation sequencing of cfDNA reference material extracted from DNA-free plasma confirmed compatibility with library preparation and sequencing workflows, providing proof of concept for a simplified cfDNA extraction strategy for amplification-based liquid biopsy applications.
- 2 April 2026
- Published by Springer Nature in Scientific Reports
- Vol. 16 (1)
Open AccessProof of concept for aqueous two-phase system-based extraction of cell-free DNA from plasma for liquid biopsy applications
Efficient extraction of circulating cell-free DNA (cfDNA) from plasma is critical for liquid biopsy applications, but remains challenging due to cfDNA’s short fragment size, low concentration, and the presence of interfering proteins and genomic DNA. This study presents a simple extraction process based on aqueous two-phase system (ATPS) capture and reverse elution purification as a potentially lysis-free alternative to adsorption-based methods. Short DNA fragments selectively partitioned into the salt-rich bottom phase, achieving up to 65% recovery after purification while removing 99.7% of plasma proteins. Reverse elution enabled efficient desalting and up to fourfold DNA concentration under mild, aqueous conditions. The extracts showed no qPCR inhibition and displayed a cfDNA-like size profile with a cutoff around 750 bp, indicating selective enrichment of short fragments. Although the total yield was slightly lower than that of the QIAamp Circulating Nucleic Acid Kit (QIAGEN), the ATPS workflow substantially reduced processing time, equipment needs, and cost. Next-generation sequencing of cfDNA reference material extracted from DNA-free plasma confirmed compatibility with library preparation and sequencing workflows, providing proof of concept for a simplified cfDNA extraction strategy for amplification-based liquid biopsy applications.
- Open Access
- 18 March 2026
- Published by Elsevier in Journal of Pharmaceutical Sciences
- Vol. 115 (6) , 104257
Comprehensive stress study on recombinant adeno-associated virus vectors: Evaluating the capabilities of established analytical techniques
- 18 March 2026
- Published by Elsevier in Journal of Pharmaceutical Sciences
- Vol. 115 (6) , 104257
Open AccessComprehensive stress study on recombinant adeno-associated virus vectors: Evaluating the capabilities of established analytical techniques
- Open Access
- 20 December 2025
- Published by Elsevier in Journal of Chromatography A
- Vol. 1767, 466644
Selectivity for full AAV capsids in affinity capture with camelid ligands
- 20 December 2025
- Published by Elsevier in Journal of Chromatography A
- Vol. 1767, 466644
Open AccessSelectivity for full AAV capsids in affinity capture with camelid ligands
- Open Access
- 28 November 2025
- Published by MDPI AG in Applied Sciences
- Vol. 15 (23) , 12648
Monitoring Storage Stability of 3D Printed Hydrogels
Bioprinting of Advanced Therapy Medicinal Products offers promising new strategies for personalized medicine, but it requires comprehensive, non-destructive characterization and quality monitoring. To support patients with tailor-made constructs composed of hydrogels and cells derived from allogeneic donors or autologous samples, several challenges must be addressed—such as on-demand production, robust manufacturing, appropriate storage and logistics, and destruction-free quality control—before successful translation into clinical applications or pharmacy is possible. Although experience in cryo-preservation, blood banking, and organ donation helps to identify critical process parameters, detecting variations in manufacturing and ensuring product stability remain essential. Quality monitoring of 3D-printed objects before and after storage by magnetic resonance imaging (MRI) is complemented here by measurements of total mass and volume. These established methods provide rapid, non-destructive feedback and have well-characterized statistical limitations. Total mass can be assessed quickly; however, such integral measurements do not reveal information about internal structures. MRI, in contrast, offers detailed, spatially resolved insights. By combining these analytical modalities, we quantitatively analyzed the storage stability of 3D-printed hydrogels—without living cells in this study—in order to demonstrate and validate the analytical approach. We describe a workflow for measuring mass and geometry of 3D-printed hydrogel lattices before and after storage under varying process parameters. Critical quality attributes (cQAs), including overall and internal structural fidelity as well as mass conservation, were monitored. The presented workflow supports the development of cryopreservation protocols and has potential applications in biomaterial development for bioprinting and in quality assessment of tailor-made artificial tissues.
- 28 November 2025
- Published by MDPI AG in Applied Sciences
- Vol. 15 (23) , 12648
Open AccessMonitoring Storage Stability of 3D Printed Hydrogels
Bioprinting of Advanced Therapy Medicinal Products offers promising new strategies for personalized medicine, but it requires comprehensive, non-destructive characterization and quality monitoring. To support patients with tailor-made constructs composed of hydrogels and cells derived from allogeneic donors or autologous samples, several challenges must be addressed—such as on-demand production, robust manufacturing, appropriate storage and logistics, and destruction-free quality control—before successful translation into clinical applications or pharmacy is possible. Although experience in cryo-preservation, blood banking, and organ donation helps to identify critical process parameters, detecting variations in manufacturing and ensuring product stability remain essential. Quality monitoring of 3D-printed objects before and after storage by magnetic resonance imaging (MRI) is complemented here by measurements of total mass and volume. These established methods provide rapid, non-destructive feedback and have well-characterized statistical limitations. Total mass can be assessed quickly; however, such integral measurements do not reveal information about internal structures. MRI, in contrast, offers detailed, spatially resolved insights. By combining these analytical modalities, we quantitatively analyzed the storage stability of 3D-printed hydrogels—without living cells in this study—in order to demonstrate and validate the analytical approach. We describe a workflow for measuring mass and geometry of 3D-printed hydrogel lattices before and after storage under varying process parameters. Critical quality attributes (cQAs), including overall and internal structural fidelity as well as mass conservation, were monitored. The presented workflow supports the development of cryopreservation protocols and has potential applications in biomaterial development for bioprinting and in quality assessment of tailor-made artificial tissues.